Fawaz Ali D. 4
4 · Tyra Biosciences, Inc. · Filed May 16, 2022
Insider Transaction Report
Form 4
Fawaz Ali D.
General Counsel and Secretary
Transactions
- Award
Stock Option (Right to Buy)
2022-05-16+2,301→ 2,301 totalExercise: $7.68Exp: 2032-05-15→ Common Stock (2,301 underlying) - Award
Stock Option (Right to Buy)
2022-05-16+3,752→ 3,752 totalExercise: $7.68Exp: 2032-05-15→ Common Stock (3,752 underlying) - Award
Stock Option (Right to Buy)
2022-05-16+361,586→ 361,586 totalExercise: $7.68Exp: 2032-05-15→ Common Stock (361,586 underlying)
Footnotes (2)
- [F1]The option vests based on achievement of a performance objective.
- [F2]25% of the shares subject to the option shall vest on May 16, 2023, and 1/36th of the remaining number of shares subject to the option vest monthly thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date.